Sotrovimab constitute a emerging class of protein therapies designed to neutralize the SARS-CoV-2 pathogen . Originally , sotrovimab, developed by Vir Biotechnology , demonstrated considerable benefit https://rebeccaekjd075210.pointblog.net/sotrovimab-vir-7831-a-deep-analysis-into-the-immunoglobulin-intervention-94175974